Abstract
The Asymmetric Radioelectric Converter - REAC (acronym of the term in English Radioelectric Asymmetric Conveyer) is a radiofrequency equipment whose interaction with the body allows the reorganization of cell polarity, through the rebalancing of endogenous bioelectric fields, functionally modulating adaptive responses. 1,2,3
The uniqueness of the REAC is not exactly the emission of radiofrequency waves, but the physical link created between the patient's body and the device whose contact it establishes. The therapeutic use of REAC technology is established through an electrical gradient that adjusts ionic fluxes and optimizes molecular mechanisms, regulating the asymmetry and polarity of cells. 1,4,5
REAC neuromodulation emits a radiofrequency field in the 5.8 GHz band applied through a handle acting at cortical levels, whereas biomodulation protocols are used locally based on a 2.4 Hz frequency, applied by cables multiprobes in a body area limited by a laminar probe.1,2 Thus, the difference between the protocols is the frequency used and not necessarily the applied area, such as the Cervicobrachial Neuropsychophysical Optimization (NPPO-CB), which is a neuromodulation protocol applied in a region limited by a laminar probe 3 (Figure 1).
Figure 1. Schematic representation of the application of biomodulation and neuromodulation protocols by REAC technology.
REAC Technology (A); Emission of radio frequency waves (B); Handle for applying neuromodulation (C); Specific point of the neuropostural optimization protocol (NPO), in the direction of the draft in the pinna, indicated by the green dot in the numeral 1 (D); Seven application points of the neuropsychophysical optimization protocol (NPPO) in the pinna (E); Multiprobe cables connected to the laminar sheet in the tissue secured by a mesh for the application of biomodulation protocols (F). GHz. Source: Authors, 2021.
Biomodulation consists of a set of protocols called Basic Tissue Optimization (TO-B), Reparative Tissue Optimization (TO-RPR), Regenerative Tissue Optimization (TO-RGN), Neuro-Regenerative Tissue Optimization (TO-RGN-N) and Optimization Chondral Regenerative Tissue (TO-RGN-C), these protocols are applied through a laminar probe, connected by multi-probe cables directly to the equipment, over a specific area of the body. 4,5,6,7,8,9,10,11
Studies have shown the effects of neuro and radioelectric biomodulation by REAC technology in reducing neuronal damage, with positive results for the nervous system, neurological and neurodegenerative diseases 10, as well as in the treatment of generalized anxiety disorders,12 effects of proliferation, migration and cell organization and healing, 9,11 expression of cardiogenic, myogenic, adipogenic, osteogenic, vasculogenic and neuronal genes,2,7,13 immune response modulation, 14,10 cell antisenescence 14,9 and induction of cell differentiation are among the results observed 15
The reprogramming and optimization of endogenous bioelectricity allows accessing epigenetic processes and therefore gene expression, in contrast to inflammatory, senescent and neurodegenerative patterns, thus establishing a range of perspectives and options for applicability in various health conditions for REAC technology, leaving move towards a greater contingent of clinical trials 16,4,17
References
Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S. Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress. Neuropsychiatr Dis Treat. 2019
Basoli V, Santaniello S, Rinaldi S, Fontani V, Pigliaru G, Wieser M, et al. Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs. PLoS ONE [Internet]. 2019 Jan 23 [Acesso em: 2020 Jan 02]; 14(1):e0211188. DOI: https://doi.org/10.1371/journal.pone.0211188.
Pinheiro Barcessat AR, Nolli Bittencourt M, Duarte Ferreira L, et al. REAC Cervicobrachial Neuromodulation Treatment of Depression, Anxiety, and Stress During the COVID-19 Pandemic [published correction appears in Psychol Res Behav Manag. 2021 Jan 05;13:1373]. Psychol Res Behav Manag. 2020;13:929-937. Published 2020 Nov 9. doi:10.2147/PRBM.S275730
Basoli V, Santaniello S, Rinaldi S, Fontani V, Pigliaru G, Wieser M, et al. Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs. PLoS ONE. 2019 Jan 23; 14(1):e0211188.
Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, Lotti Margotti M, Bagella L, Fontani V, Ventura C. Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age (Dordr). 36(1):9-20, 2014.
Rinaldi S, Meloni MA, Galleri G, Maioli M, Pigliaru G, Cugia G, et al.. Radio Electric Asymmetric Conveyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity. PLoS One [Internet]. 2018 Ago 06 [Acesso em 01 Nov 2020]; 13:1 - 16.
Rinaldi S, Maioli M, Pigliaru G, Castagna A, Santaniello S, Basoli V, et al. Stem cell senescence. Effects of REAC technology on telomerase-independent and telomerase-dependent pathways. Sci Rep [Internet]. 2014 Sep 16 [Acesso em: 2020 Nov 1]; 4:1-8.
Collodel G, Fioravanti A, Pascarelli NA, Lamboglia A, Fontani V, Maioli M, et al. Effects of regenerative radioelectric asymmetric conveyer treatment on human normal and osteoarthritic chondrocytes exposed to IL-1β. A biochemical and morphological study. Clin Interv Aging [Internet]. 2013 Mar 19 [Acesso em: 2020 Nov 1]; 8:309-316.
Rinaldi S, Iannaccone M, Magi GE, Constantini E, Castagna A, Passino ES, et al. Physical reparative treatment in reptiles. BMC Vet Res [Internet]. 2013 Feb 26 [Acesso em: 2020 Nov 1];9:1-8. DOI: https://doi.org/10.1186/1746-6148-9-39.
Panaro MA, Aloisi A, Nicolardi G, Lofrumento DD, Nuccio FD, Pesa VL, et al. Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration. Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration. Neurosci Bull [Internet]. 2017 Nov 10 [Acesso em: 2020 Nov 1];34:270–282.
Passino ES, Rocca S, Caggiu S, Columbano N, Castagna A, Fontani V, et al. REAC regenerative treatment efficacy in experimental chondral lesions: a pilot study on ovine animal model. Clin Interv Aging [Internet]. 2017 Sep 14 [Acesso em: 2020 Nov 1];12:1471—1479. DOI: https://doi.org/10.2147/CIA.S140976.
Zippo AG, Rinaldi S, Pellegata G, Caramenti GC, Valente M, Fontani V, Biella GE. Electrophysiological effects of non-invasive Radio Electric Asymmetric Conveyor (REAC) on thalamocortical neural activities and perturbed experimental conditions. Sci Rep. 2015
Kumar V, Abbas A, Fausto N. Robbins e Cotran – Patologia – Bases Patológicas das Doenças. 9. ed. Rio de Janeiro: Elsevier, 2013.
Olazaran, J., Gonzalez, B., Osa-Ruiz, E., Felipe-Ruiz, S., Boyano, I., Fontani, V., ... & Martínez-Martín, P. Motor effects of radio electric asymmetric conveyer in Alzheimer's disease: results from a cross-over trial. Journal of Alzheimer's Disease, 42(1), 325-332, 2014.
Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Gualini S, et al. Radio Electric Conveyed Fields Directly Reprogram Human Dermal Skin Fibroblasts toward Cardiac, Neuronal, and Skeletal Muscle-Like Lineages. Cell Transplant [Internet]. 2013 Jul 01 [Acesso em: 1 nov 2020]; 22(7):1227-1235.
Mura M, Castagna A, Fontani V, Rinaldi S. Preliminary fMRI pilot study of neuropostural optimization with a non-invasive asymmetric radioelectric brain stimulation protocol in functional dysmetria. Neuropsychiatr Dis Treat. 2012; 8 : 149-154.
Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S. Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress. Neuropsychiatr Dis Treat. 2019

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Ester Suane Lima Monteiro , João Douglas Quaresma de Oliveira , Ana Rita Pinheiro Barcessat